10-10/11 :: October/November 2010
nanotimes EU-Projects
Sabio. This completed project focused on ultrahigh sensitivity slot-waveguide biosensor on a highly in- tegrated chip for simultaneous diagnosis of multiple diseases.
http://ist-sabio.org http://www.siliconphotonics.eu/ Low Cost Inks for Printed Electronics
The Clip project aiming at developing low cost inks for printed electronics applications was launched. The EUR2.7 million large project will enable small and medium sized EU based businesses to address the growing potential of printed electronics. Clip is financed under the EU‘s 7th Framework programme for Research and Technological Development (FP7), Research for SME Associations programme.
Over the last 20 years the sophistication of printing systems and technology has grown to a point where the next step towards realising printed electronics will be in reach for a range of applications and com- panies, including SMEs. However, to do this, there is a need for a low cost conductive ink, which can act as the platform for developing more complicated and valuable technologies. This will accelerate the time to market for new electronic enabled products by utilising printing technologies that already exist within the EU.
http://www.clip-fp7.eu/press
65
Mapping the Success of Nanobiotechnology
The crucial task of the EU-funded project Euron- anobio was to set out a research path to steer the European nanobiotech industry to success over the shortest time in the most efficient way. The main aim was to define the capacity of nanobiotechnology in Europe and then chart the appropriate roadmap for its implementation.
First, project members analysed the present systems and networks in research, education and training. Once this was in place, all stakeholders were invited to give their opinion as to how to extend this com- plex infrastructure. Key players come from govern- ments, research, industry, and, all-importantly for any biotech initiative, advisors on ethics.
Euronanobio proposed no less than 15 recommen- dations for a distributed biotech European network. These involved four dimensions – research, educa- tion, technology transfer and ethical legal and so- cial aspects (ELSA). High level dissemination of the findings through the internet and conferences will help to maintain the rapid yet stable evolution of nanobiotechnology.
Contact: Patrick Boisseau, COMMISSARIAT ENERGIE ATOMIQUE CEA, LETI, Project manager, 17, avenue des martyrs, 38054 Grenoble, France, Phone: +33-4- 38783854
http://www.euronanobio.eu
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79